Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium-binding and coiled-coil domain-containing protein 1 (CALCOCO1) is a multifunctional cytosolic and nuclear protein involved in selective autophagy and transcriptional coactivation. CALCOCO1 acts as a soluble endoplasmic reticulum (ER)-phagy receptor, specifically facilitating the autophagic degradation of tubular ER subdomains during proteotoxic and nutrient stress. It interacts directly with ER membrane tethering proteins VAPA and VAPB via a conserved FFAT-like motif, and with ATG8-family autophagy proteins (preferentially GABARAPs) via LIR and UIR motifs, thereby serving as a platform for autophagosome formation and cargo specificity. CALCOCO1 is also known as a coactivator for aryl hydrocarbon and nuclear receptors, recruited to gene promoters either directly or via interaction with additional coactivators, contributing to the activation of transcriptional programs (such as Wnt/CTNNB1 signaling and gamma-globin promoter activation in erythroid cells). The protein has paralogs TAX1BP1 and NDP52, sharing domain architecture and autophagy functions. Disease associations include roles in cancer dynamics—particularly sarcoma and pancreatic cancer—potentially linking autophagy, cell stress adaptation, and transcriptional regulation. CALCOCO1 has not been directly drugged or validated as a clinical biomarker but remains a molecular node at the interface of cell metabolism, stress response, and gene expression.
No current therapeutic drugs act directly on this protein; mechanistically, would mediate selective autophagy and transcription regulation if targeted
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium-binding and coiled-coil domain-containing protein 1 (CALCOCO1).